ArticleInternational journal of nephrology2026
The Spectrum of HIV-Associated Kidney Pathology at a Tertiary Centre in South Africa.
Article in International journal of nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Spectrum of HIV-Associated Kidney Pathology at a Tertiary Centre in South Africa.International journal of nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: South Africa has one of the highest prevalences of human immunodeficiency virus (HIV) infection worldwide. Kidney disease is a common and important complication of HIV. This study describes biopsy-proven kidney pathology in people living with HIV (PLHIV) over 29 years at a South African centre, comparing patterns before and after antiretroviral therapy (ART) rollout. Methods: This retrospective descriptive study included PLHIV who underwent native kidney biopsy at Tygerberg Hospital during the period of 1 January 1992 to 31 December 2020. Patients were categorised by biopsy year into a pre-ART rollout period (before 2004) and a post-ART rollout period (2004 or later). Results: The cohort included 554 PLHIV, mostly biopsied post-ART rollout (90.1%). Mean age was 36.5 years, with a balanced sex distribution. During the post-ART period, 54.8% were on ART at biopsy. HIVAN was diagnosed in 45.7%, of which one-third had an additional histopathological pattern of injury. In the pre-ART rollout period, HIVAN was the most prevalent diagnosis (60.0%), whereas a lower prevalence was observed post-ART rollout (44.1%). During the post-ART rollout period, more than half of patients (55.9%) exhibited only non-HIVAN kidney pathology, with immune-complex-mediated glomerulonephritis (52.7%) and tubulointerstitial disease (39.7%) the most common. Conclusion: This study describes the spectrum of kidney pathology in PLHIV at a South African tertiary centre over nearly three decades, highlighting a significant HIVAN burden overall. We observed a lower proportion of patients with HIVAN following ART rollout, coinciding with an increase in non-HIVAN pathologies like immune complex glomerulonephritis and tubulointerstitial disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.